Prevalence of extrapulmonary tuberculosis and factors influencing successful treatment outcomes among notified cases in South India.

Tuberculosis (TB) remains a significant public health issue globally, with extra pulmonary tuberculosis (epTB) accounting for a considerable number of TB cases. This study aims to improve our understanding of epTB epidemiology by evaluating treatment outcomes and identifying factors associated with positive and negative treatment results in epTB patients. A retrospective study was conducted from January 1, 2016, to December 31, 2019.

Evaluation of Tridax procumbens Secondary Metabolites Anti-Tuberculosis Activity by In Vitro and In Silico Methods.

Mycobacterium tuberculosis is a human pathogen that causes Tuberculosis (TB) disease. Researchers have reported the activity of traditional medicinal plants against human pathogens. However, antimycobacterial studies of medicinal plants against M.

Algal carbohydrates: Sources, biosynthetic pathway, production, and applications.

Algae play a significant role in the global carbon cycle by utilizing photosynthesis to efficiently convert solar energy and atmospheric carbon dioxide into various chemical compounds, notably carbohydrates, pigments, lipids, and released oxygen, making them a unique sustainable cellular factory. Algae mostly consist of carbohydrates, which include a broad variety of structures that contribute to their distinct physical and chemical properties such as degree of polymerization, side chain, branching, degree of sulfation, hydrogen bond etc., these features play a crucial role in regulating many biological activity, nutritional and pharmaceutical properties.

Pyrazinamide resistance due to pncA gene mutation and its association with treatment outcome among tuberculosis patients of South India- A longitudinal observational study.

Introduction: Mycobacterium tuberculosis has been extensively studied for mutations leading to drug resistance. Pyrazinamide is a drug acting on the semi-dormant bacteria that is responsible for relapse of tuberculosis. This drug helped reduce the treatment duration of tuberculosis from nine to six months.